Carbidopa, Levodopa and Entacapone 25 mg/1

Carbidopa, Levodopa and Entacapone 25 mg/1 tablets are a combination medication used to manage symptoms of Parkinson's disease. This formulation helps improve mobility and reduce tremors, offering a comprehensive approach to symptom management.

Carbidopa, Levodopa and Entacapone 25 mg/1 tablets are primarily used to treat Parkinson's disease. The combination of these active ingredients works to increase dopamine levels in the brain, which can help alleviate symptoms such as stiffness, tremors, and difficulty moving. This medication is often prescribed to improve motor function and quality of life for individuals with Parkinson's disease.

Common effects of Carbidopa, Levodopa and Entacapone 25 mg/1 tablets may include nausea, dizziness, and headaches. Some users may also experience involuntary movements or changes in blood pressure. These effects can vary from person to person and may diminish over time as the body adjusts to the medication.

It is important to handle Carbidopa, Levodopa and Entacapone 25 mg/1 tablets with care. Store them in a cool, dry place away from direct sunlight and out of reach of children. Always follow the guidance of a healthcare professional regarding the use of this medication, and be aware of any potential allergic reactions or adverse effects.

Carbidopa, Levodopa and Entacapone 25 mg/1 tablets may interact with certain medications, including other Parkinson's disease treatments, antidepressants, and blood pressure medications. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol consumption should be moderated while using this medication.